{"title":"第一人称,Saba Naghipour","authors":"","doi":"10.1242/dmm.050247","DOIUrl":null,"url":null,"abstract":"\n First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Saba Naghipour is first author on ‘ A gut microbiome metabolite paradoxically depresses contractile function while activating mitochondrial respiration’, published in DMM. Saba is a PhD candidate in the lab of Eugene Du Toit at Griffith University, Southport, Australia, investigating the role of trimethylamine-N-oxide in the development of cardiovascular disease.","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"First person – Saba Naghipour\",\"authors\":\"\",\"doi\":\"10.1242/dmm.050247\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Saba Naghipour is first author on ‘ A gut microbiome metabolite paradoxically depresses contractile function while activating mitochondrial respiration’, published in DMM. Saba is a PhD candidate in the lab of Eugene Du Toit at Griffith University, Southport, Australia, investigating the role of trimethylamine-N-oxide in the development of cardiovascular disease.\",\"PeriodicalId\":141347,\"journal\":{\"name\":\"Disease Models & Mechanisms\",\"volume\":\"6 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Disease Models & Mechanisms\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1242/dmm.050247\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Disease Models & Mechanisms","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1242/dmm.050247","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
《第一人称》是对发表在《疾病模型与机制》上的论文的第一作者的一系列采访,帮助研究人员在论文的同时提升自己。Saba Naghipour是《肠道微生物代谢物在激活线粒体呼吸的同时矛盾地抑制收缩功能》的第一作者,发表在《DMM》杂志上。Saba是澳大利亚南港格里菲斯大学尤金·杜·托伊特实验室的博士候选人,研究三甲胺- n -氧化物在心血管疾病发展中的作用。
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Saba Naghipour is first author on ‘ A gut microbiome metabolite paradoxically depresses contractile function while activating mitochondrial respiration’, published in DMM. Saba is a PhD candidate in the lab of Eugene Du Toit at Griffith University, Southport, Australia, investigating the role of trimethylamine-N-oxide in the development of cardiovascular disease.